10-Q/A: FiEE, Inc. Restates Q1 2024 Financials Due to Share Count Errors, Reveals Steep Revenue Decline

FiEE, Inc. has filed an amended quarterly report for Q1 2024, restating financial statements due to errors in reported common stock outstanding and related earnings per share calculations, alongside a significant year-over-year revenue drop.

Summary

• FiEE, Inc. (formerly Minim, Inc.) filed an Amendment No. 1 to its Quarterly Report on Form 10-Q for the period ended March 31, 2024, to amend and restate certain financial statements and certifications.
• The restatement was initiated because the Audit Committee, in consultation with management, concluded that the previously filed financial statements for Q1 2024 should no longer be relied upon due to errors in recording and reporting shares of common stock outstanding, including earnings per share.
• The corrected outstanding shares for the fiscal year ended December 31, 2023, are 2,789,020, an increase from the previously reported 2,632,809 shares.
• For the period ended March 31, 2024, the corrected outstanding shares are 2,965,900, an increase from the previously reported 2,809,689 shares.
• The error in outstanding shares did not impact the period ended March 31, 2023.
• As a result of the restatement, the weighted average shares for Q1 2024 are 2,926,593, compared to the original 2,770,382.
• The restated basic and diluted net loss per share for Q1 2024 is $1.11, an improvement from the original $1.18 per share.
• Net sales for Q1 2024 were $639,893, a substantial decrease from $10,751,785 in Q1 2023.
• Gross profit for Q1 2024 was $207,259, down significantly from $2,609,205 in Q1 2023.
• The company reported a net loss of $(3,258,955) for Q1 2024, an improvement from a net loss of $(4,070,457) in Q1 2023.
• Operating expenses for Q1 2024 included a gain of $2,364,955 from vendor liability forgiveness, net of asset transfers.
• Cash and cash equivalents increased to $1,027,057 as of March 31, 2024, from $709,322 as of December 31, 2023.
• Total current assets significantly decreased to $1,077,624 as of March 31, 2024, from $11,399,114 as of December 31, 2023, primarily due to a reduction in inventories to zero and a sharp decline in accounts receivable.
• Total current liabilities also significantly decreased to $1,419,526 as of March 31, 2024, from $12,244,048 as of December 31, 2023, mainly due to a reduction in accounts payable.
• Total stockholders' equity decreased to $83,243 as of March 31, 2024, from $115,917 as of December 31, 2023.
• During Q1 2024, the company issued 2,000,000 shares of preferred stock for $1,358,573 and warrants valued at $1,441,427.

Sentiment

Score: 3

Explanation: The necessity of a financial restatement due to fundamental errors in share count is a significant negative, indicating internal control weaknesses and potentially eroding investor trust. While the restated EPS is numerically less negative, the underlying business performance shows a drastic decline in revenue and gross profit year-over-year. The preferred stock issuance and warrants suggest a need for capital, which, combined with poor operational performance, points to a challenging outlook.

Positives

• The restated net loss per share for Q1 2024 improved to $1.11 from the originally reported $1.18, making the loss numerically smaller.
• Net loss for Q1 2024 decreased to $(3,258,955) from $(4,070,457) in Q1 2023, indicating a reduction in the overall loss.
• Operating loss for Q1 2024 decreased to $(3,269,679) from $(3,925,470) in Q1 2023, showing an improvement in operating performance.
• Cash and cash equivalents increased to $1,027,057 as of March 31, 2024, from $709,322 as of December 31, 2023.
• Accounts payable saw a significant reduction to $398,786 as of March 31, 2024, from $11,143,693 as of December 31, 2023.
• The company recognized $2,364,955 from vendor liability forgiveness, net of asset transfers, which positively impacted operating expenses in Q1 2024.

Negatives

• The necessity of restating financial statements due to errors in recording and reporting common stock outstanding indicates significant internal control deficiencies.
• Previously filed financial statements for Q1 2024 should no longer be relied upon, which can erode investor confidence.
• Net sales for Q1 2024 plummeted to $639,893, a drastic 94% decrease from $10,751,785 in Q1 2023.
• Gross profit significantly declined to $207,259 in Q1 2024 from $2,609,205 in Q1 2023, reflecting severe pressure on profitability.
• Total current assets dramatically decreased to $1,077,624 as of March 31, 2024, from $11,399,114 as of December 31, 2023, largely due to inventories being reduced to zero and a sharp drop in accounts receivable.
• Total stockholders' equity decreased to $83,243 as of March 31, 2024, from $115,917 as of December 31, 2023, indicating a weakening financial position.

Risks

• Errors in financial reporting, specifically regarding common stock outstanding and earnings per share, indicate potential material weaknesses in internal control over financial reporting.
• The need for a financial restatement can damage investor confidence, lead to increased scrutiny from regulatory bodies, and potentially result in legal or compliance costs.
• The significant year-over-year decline in net sales and gross profit suggests severe business challenges, market contraction, or a fundamental shift in operations that could impact future viability.
• The substantial reduction in inventories to zero as of March 31, 2024, raises questions about the company's ability to fulfill future sales and maintain operational continuity.
• A decrease in total stockholders' equity indicates a weakening financial position and reduced buffer against future losses.

Future Outlook

No specific forward-looking statements or guidance are provided in this amendment. The filing explicitly states it has not been updated or amended to give effect to any subsequent events beyond those that existed as of the original filing date.

Management Comments

• "Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report."
• "Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report."
• "The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures... and internal control over financial reporting... and we have: Designed such disclosure controls and procedures... to ensure that material information... is made known to us... Designed such internal control over financial reporting... to provide reasonable assurance regarding the reliability of financial reporting..."
• "The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company."

Industry Context

This filing primarily addresses company-specific financial restatement issues due to internal errors rather than broader industry trends. While the significant decline in sales and gross profit from Q1 2023 to Q1 2024 could suggest industry headwinds or company-specific operational challenges, the filing does not provide explicit industry context or comparative analysis.

Comparison to Industry Standards

• The filing does not provide information to compare the company's performance or financial health against specific comparable companies, projects, or industry benchmarks. The focus is on correcting internal financial reporting errors and presenting the restated figures.

Corporate Governance

Stakeholder Impact

• Shareholders: Existing shareholders face uncertainty due to restated financials and potential concerns about internal controls. The preferred stock issuance and warrants could dilute future common shareholder value.
• Investors: Investors should no longer rely on previous Q1 2024 financial statements and must use the restated figures, which show a significant decline in revenue but a numerically improved (less negative) EPS.
• Regulatory Authorities: The SEC will review the restatement, potentially leading to further inquiries regarding internal controls and compliance.

Next Steps

• No specific future actions, events, or milestones are mentioned in this amendment beyond the filing itself.

Key Dates

Recommendation

The necessity of a financial restatement due to fundamental errors in share count is a severe red flag, indicating significant internal control deficiencies and a lack of reliable financial reporting. While the restated EPS is numerically less negative, the underlying business performance shows a catastrophic decline in net sales (from over $10 million to $639k) and gross profit year-over-year. The company's total current assets have plummeted, and while liabilities also decreased, the overall financial health appears precarious, with stockholders' equity significantly reduced. The issuance of preferred stock and warrants suggests a need for capital amidst deteriorating operational results. These factors collectively point to a company facing severe operational and governance challenges, making it a high-risk investment with significant downside potential.

Keywords

FiEE Inc., Minim Inc., Financial Restatement, 10-Q/A, SEC Filing, Common Stock Outstanding, Earnings Per Share, Financial Errors, Internal Controls, Net Sales Decline, Quarterly Report, Corporate Governance